Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS)

14 filings reported holding BRNS - Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share as of Q2 2025.
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.31M shares of 40.3M outstanding shares and own 23.11% of the company stock.
Largest 10 shareholders include M&G PLC (5.2M shares), Alphabet Inc. (1.51M shares), HSG Holding Ltd (1.42M shares), DC Funds, LP (642K shares), Baird Financial Group, Inc. (192K shares), Johns Hopkins University (122K shares), GILEAD SCIENCES, INC. (99.5K shares), HighTower Advisors, LLC (37.5K shares), RENAISSANCE TECHNOLOGIES LLC (36.3K shares), and CITADEL ADVISORS LLC (16.2K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.